Larvol Delta - Aprea-Therapeutics-Provides-Clinical-Update-from-ACESOT1051-Trial-Showing-Early-Signals-of-Activity-for-WEE1-Kinase-Inhibitor-APR1051

APR-1051 - Aprea

https://www.globenewswire.com/news-release/2025/10/24/3172792/0/en/Aprea-Therapeutics-Provides-Clinical-Update-from-ACESOT-1051-Trial-Showing-Early-Signals-of-Activity-for-WEE1-Kinase-Inhibitor-APR-1051.html

Oct 24, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next